PHARMING GRP SP. ADRS (PHG) — Financial Flexibility Index

Latest as of December 2025: 0.05x

PHARMING GRP SP. ADRS (PHG) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of €10.98 Million (operating CF €10.71 Million minus capex €269.00K) represents 0% of total liabilities (€222.86 Million). Check how strategically is PHARMING GRP SP. ADRS's equity deployed to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

0.05x
Free Cash Flow / Total Liabilities

Free Cash Flow

€10.98 Million
Operating CF − Capex

Total Liabilities

€222.86 Million
EUR

Capital Expenditures

€269.00K
EUR

PHARMING GRP SP. ADRS Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for PHARMING GRP SP. ADRS across 5 annual periods. See how liquid is PHARMING GRP SP. ADRS's working capital to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for PHARMING GRP SP. ADRS (2021–2025)

Year-by-year free cash flow to debt coverage for PHARMING GRP SP. ADRS. For the full company profile including market capitalisation, see PHARMING GRP SP. ADRS market capitalisation.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2025 0.25x €55.46 Million €54.71 Million €222.86 Million ▲ +4557.3%
2024 -0.01x €-999.00K €-1.79 Million €178.92 Million ▲ +91.4%
2023 -0.06x €-15.84 Million €-17.30 Million €244.07 Million ▼ -158.7%
2022 0.11x €24.43 Million €22.46 Million €221.16 Million ▼ -58.6%
2021 0.27x €54.56 Million €37.84 Million €204.40 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities